A detailed history of Novo Holdings transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Novo Holdings holds 1,500,000 shares of FDMT stock, worth $8.72 Million. This represents 1.13% of its overall portfolio holdings.

Number of Shares
1,500,000
Previous 1,400,000 7.14%
Holding current value
$8.72 Million
Previous $29.4 Million 44.82%
% of portfolio
1.13%
Previous 2.1%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$10.81 - $27.22 $1.08 Million - $2.72 Million
100,000 Added 7.14%
1,500,000 $16.2 Million
Q1 2024

May 15, 2024

SELL
$17.03 - $35.87 $1.7 Million - $3.59 Million
-100,000 Reduced 6.67%
1,400,000 $44.6 Million
Q4 2023

Feb 14, 2024

BUY
$9.76 - $21.25 $2.93 Million - $6.38 Million
300,000 Added 25.0%
1,500,000 $30.4 Million
Q3 2023

Nov 14, 2023

BUY
$12.64 - $19.76 $2.53 Million - $3.95 Million
200,000 Added 20.0%
1,200,000 $15.3 Million
Q2 2023

Aug 14, 2023

BUY
$15.16 - $23.26 $4.55 Million - $6.98 Million
300,000 Added 42.86%
1,000,000 $18.1 Million
Q1 2023

May 15, 2023

BUY
$15.45 - $23.19 $10.8 Million - $16.2 Million
700,000 New
700,000 $12 Million

Others Institutions Holding FDMT

About 4D Molecular Therapeutics, Inc.


  • Ticker FDMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,382,400
  • Market Cap $188M
  • Description
  • 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...
More about FDMT
Track This Portfolio

Track Novo Holdings Portfolio

Follow Novo Holdings and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

News

Stay updated on Novo Holdings with notifications on news.